COMPARING THE OUTCOMES EXPERIENCED IN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR KIDNEY OUTCOME TRIALS TO A CANADIAN CHRONIC KIDNEY DISEASE COHORT

被引：0
|
作者：
Yi, Tae Won [1 ,2 ]
Atiquzzaman, Mohammad [3 ]
Zheng, Yuyan [3 ]
Smyth, Brendan [2 ,4 ]
Jardine, Meg [2 ,5 ]
Levin, Adeera [2 ,3 ,6 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[3] BC Prov Renal Agcy, Vancouver, BC, Canada
[4] St George Hosp, Dept Renal Med, Kogarah, NSW, Australia
[5] Concord Repatriat Gen Hosp, Dept Nephrol, Sydney, NSW, Australia
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
来源：
NEPHROLOGY | 2022年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [21] Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease
    Yen, Fu-Shun
    Hwu, Chii-Min
    Liu, Jia-Sin
    Wu, Yi-Ling
    Chong, Keong
    Hsu, Chih-Cheng
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 693 - 700
  • [22] Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor
    Koch, Richard A.
    Clark, Richard F.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (05) : E590 - E591
  • [23] Sodium-glucose cotransporter-2 inhibitor prescribing practices
    Alcorn, Chris
    Subarajan, Prathayini
    Kesari, Aditya
    Lockhart, Marie
    Cottrell, Daryl
    Jordan, Kim
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1136 - 1139
  • [24] Use of Sodium-glucose Cotransporter 2 Inhibitors in Patients with Chronic Kidney Disease
    Alkhunaizi, Ahmed M.
    Khairalla, Hanan
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (05) : 468 - 473
  • [25] Sodium-glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease
    Kato, Shingo
    Horita, Nobuyuki
    Utsunomiya, Daisuke
    ESC HEART FAILURE, 2022, 9 (05): : 3661 - 3662
  • [26] Inhibition of sodium-glucose cotransporter 2 to slow the progression of chronic kidney disease
    Oguz, Fabie
    Demoulin, Nathalie
    Thissen, Jean Paul
    Jadoul, Michel
    Morelle, Johann
    ACTA CLINICA BELGICA, 2022, 77 (04) : 805 - 814
  • [27] Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline
    Agarwal, Arnav
    Zeng, Xiaoxi
    Li, Sheyu
    Rayner, Daniel
    Foroutan, Farid
    Aertgeerts, Bert
    Coyac, Frederic
    Farhoumand, Pauline Darbellay
    Demaine, Andrew
    Heen, Anja Fog
    Jha, Vivekanand
    Machuve, Edward
    Nagler, Evi
    Tunnicliffe, David J.
    Guyatt, Gordon H.
    Vandvik, Per Olav
    Ponte, Belen
    Agoritsas, Thomas
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [28] Effectiveness and Safety of Sodium-Glucose Cotransporter-2 Inhibitor Continuation in Patients With Type 2 Diabetes and Late-Stage Chronic Kidney Disease
    Denny, Olivia
    Albanese, Nicole P.
    Meaney, Calvin J.
    Siwarski, Nicole E.
    Monte, Scott V.
    JOURNAL OF PHARMACY TECHNOLOGY, 2025, 41 (02) : 65 - 71
  • [29] Sodium-Glucose Cotransporter-2 Inhibitors and Prevention of Adverse Kidney Outcomes in Type 2 Diabetes: A Clinical Multiethnic Asian Cohort
    Feng, Liang
    Liew, Zhong Hong
    Bee, Yong Mong
    Jafar, Tazeen H.
    KIDNEY MEDICINE, 2025, 7 (03)
  • [30] Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
    Alicic, Radica Z.
    Neumiller, Joshua J.
    Johnson, Emily J.
    Dieter, Brad
    Tuttle, Katherine R.
    DIABETES, 2019, 68 (02) : 248 - 257
12345